Product description
Korglutide is an orally administered GLP-1 peptide developed by Caregen as a next-generation solution for weight loss and metabolic improvement. Unlike injectable GLP-1 receptor agonists (e.g., semaglutide, liraglutide), Korglutide is designed as a nutraceutical that offers once-daily oral administration, providing superior patient convenience, compliance, and regulatory accessibility.
Read more